The effect of peripheral nerve injury on disease progression in the SOD1 (G93A) mouse model of amyotrophic lateral sclerosis

被引:59
|
作者
Sharp, PS [1 ]
Dick, JRT [1 ]
Greensmith, L [1 ]
机构
[1] Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England
关键词
motoneuron survival; axotomy; motor unit; muscle force; motor neuron disease;
D O I
10.1016/j.neuroscience.2004.09.069
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Around 20% of familial cases of amyotrophic lateral sclerosis have been shown to carry mutations in Cu/Zn superoxide dismutase 1 (Cu/Zn SOW). Transgenic mice over-expressing human mutant SOD1 genes have been developed and in this study we examined the effect of nerve injury on disease progression in these mice. Firstly, disease progression in uninjured mice was characterised using physiological methods. Muscle force, contractile characteristics and motor unit survival was established at 90 days, an early symptomatic stage and also at the end-stage of the disease, at 130 days. In addition, muscle histochemistry was examined and the extent of motoneuron survival established morphologically. By 90 days of age, there is a significant reduction in muscle force, and nearly 40% of motoneurons within the sciatic motor pool have already died. By 130 days, the muscles are significantly weaker, and there is a dramatic change in the phenotype of extensor digitorum longus (EDL), which changes from a fast fatigable muscle, to a fatigue resistant muscle with a high oxidative capacity. By this stage of the disease, only 40% of motor units in EDL survive, with only 29% of motoneurons surviving within the sciatic motor pool. Following injury to the sciatic nerve in SOD1((G93A)) mice, there is an acceleration in disease progression so that 90 day old mice show deficits that are only seen at the end stage in uninjured SOD1((G93A)) mice. It is therefore possible that mutant SOD1 toxicity increases the vulnerability of motoneurons and muscles to stressful stimuli such as nerve injury. (C) 2005 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:897 / 910
页数:14
相关论文
共 50 条
  • [1] Lack of Effect of Methylene Blue in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis
    Lougheed, Rosamond
    Turnbull, John
    PLOS ONE, 2011, 6 (10):
  • [2] Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis
    Baker, David J.
    Blackburn, Daniel J.
    Keatinge, Marcus
    Sokhi, Dilraj
    Viskaitis, Paulius
    Heath, Paul R.
    Ferraiuolo, Laura
    Kirby, Janine
    Shaw, Pamela J.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2015, 9
  • [3] Comparing therapeutic modulators of the SOD1 G93A Amyotrophic Lateral Sclerosis mouse pathophysiology
    Lee, Albert J. B.
    Kittel, Tyler E. E.
    Kim, Renaid B. B.
    Bach, Thao-Nguyen
    Zhang, Tian
    Mitchell, Cassie S. S.
    FRONTIERS IN NEUROSCIENCE, 2023, 16
  • [4] The SOD1 transgene in the G93A mouse model of amyotrophic lateral sclerosis lies on distal mouse chromosome 12
    Achilli, F
    Boyle, S
    Kieran, D
    Chia, R
    Hafezparast, M
    Martin, JE
    Schiavo, G
    Greensmith, L
    Bickmore, W
    Fisher, EMC
    AMYOTROPHIC LATERAL SCLEROSIS, 2005, 6 (02): : 111 - 114
  • [5] GPNMB RESISTS SKELETAL MUSCLE LESION IN THE SOD1 (G93A) MOUSE MODEL OF AMYOTROPHIC LATERAL SCLEROSIS
    Nagahara, Y.
    Tanaka, H.
    Tsuruma, K.
    Ono, Y.
    Noda, Y.
    Nikawa, T.
    Shimazawa, M.
    Hara, H.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 195 - 195
  • [6] G93A SOD1 alters cell cycle in a cellular model of Amyotrophic Lateral Sclerosis
    Cova, Emanuela
    Ghiroldi, Andrea
    Guareschi, Stefania
    Mazzini, Giuliano
    Gagliardi, Stella
    Davin, Annalisa
    Bianchi, Marika
    Ceroni, Mauro
    Cereda, Cristina
    CELLULAR SIGNALLING, 2010, 22 (10) : 1477 - 1484
  • [7] The effect of leukaemia inhibitory factor on SOD1 G93A murine amyotrophic lateral sclerosis
    Feeney, SJ
    Austin, L
    Bennett, TM
    Kurek, JB
    Jean-Francois, MJB
    Muldoon, C
    Byrne, E
    CYTOKINE, 2003, 23 (4-5) : 108 - 118
  • [8] PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis
    Ringer, Cornelia
    Buening, Luisa-Sybille
    Schaefer, Martin K. H.
    Eiden, Lee E.
    Weihe, Eberhard
    Schuetz, Burkhard
    NEUROBIOLOGY OF DISEASE, 2013, 54 : 32 - 42
  • [9] Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse
    Massignan, Tania
    Casoni, Filippo
    Basso, Manuela
    Stefanazzi, Paola
    Biasini, Emiliano
    Tortarolo, Massimo
    Salmona, Mario
    Gianazza, Elisabetta
    Bendotti, Caterina
    Bonetto, Valentina
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 353 (03) : 719 - 725
  • [10] Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis
    Hayes-Punzo, Antonio
    Mulcrone, Patrick
    Meyer, Michael
    Mchugh, Jacalyn
    Svendsen, Clive N.
    Suzuki, Masatoshi
    AMYOTROPHIC LATERAL SCLEROSIS, 2012, 13 (03): : 311 - 314